Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $49,429 | 17 | 68.2% |
| Food and Beverage | $9,472 | 316 | 13.1% |
| Travel and Lodging | $9,128 | 33 | 12.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,500 | 2 | 6.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| INTUITIVE SURGICAL, INC. | $63,050 | 60 | $0 (2024) |
| BOSTON SCIENTIFIC CORPORATION | $1,832 | 17 | $0 (2021) |
| BIOTISSUE HOLDINGS INC. | $1,132 | 20 | $0 (2024) |
| PROCEPT BioRobotics Corporation | $1,088 | 8 | $0 (2024) |
| ABBVIE INC. | $659.89 | 45 | $0 (2024) |
| Astellas Pharma US Inc | $523.65 | 26 | $0 (2024) |
| PFIZER INC. | $440.37 | 32 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $364.26 | 13 | $0 (2024) |
| TOLMAR Pharmaceuticals, Inc. | $322.38 | 19 | $0 (2021) |
| Sumitomo Pharma America, Inc. | $270.61 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $24,279 | 65 | INTUITIVE SURGICAL, INC. ($21,734) |
| 2023 | $35,719 | 55 | Intuitive Surgical, Inc. ($34,852) |
| 2022 | $4,269 | 50 | Intuitive Surgical, Inc. ($3,517) |
| 2021 | $1,334 | 51 | Intuitive Surgical, Inc. ($169.64) |
| 2020 | $944.66 | 48 | Intuitive Surgical, Inc. ($182.74) |
| 2019 | $2,168 | 61 | Boston Scientific Corporation ($1,250) |
| 2018 | $3,462 | 33 | Intuitive Surgical, Inc. ($2,595) |
| 2017 | $352.84 | 5 | BOSTON SCIENTIFIC CORPORATION ($146.34) |
All Payment Transactions
368 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $74.14 | General |
| 12/23/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $73.85 | General |
| 12/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: Oncology | ||||||
| 12/13/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Oncology | ||||||
| 12/12/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,000.00 | General |
| Category: SURGERY | ||||||
| 12/04/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $500.00 | General |
| Category: SURGERY | ||||||
| 11/26/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Education | Cash or cash equivalent | $4,000.00 | General |
| Category: SURGERY | ||||||
| 11/20/2024 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | Cash or cash equivalent | $24.64 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $27.98 | General |
| Category: Oncology | ||||||
| 11/11/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $101.51 | General |
| 11/07/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $74.14 | General |
| 11/07/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $73.85 | General |
| 11/04/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/01/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/23/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Education | Cash or cash equivalent | $4,000.00 | General |
| Category: SURGERY | ||||||
| 10/23/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | Cash or cash equivalent | $150.00 | General |
| Category: SURGERY | ||||||
| 10/18/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: HORMONE THERAPY | ||||||
| 10/15/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $184.27 | General |
| Category: SURGERY | ||||||
| 10/11/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $26.90 | General |
| Category: Oncology | ||||||
| 10/09/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $19.00 | General |
| Category: SURGERY | ||||||
| 10/07/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: HORMONE THERAPY | ||||||
| 10/04/2024 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | Cash or cash equivalent | $25.10 | General |
| Category: ONCOLOGY | ||||||
| 10/03/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $353.37 | General |
| Category: SURGERY | ||||||
| 10/03/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $19.00 | General |
| Category: SURGERY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 436 | 641 | $163,223 | $55,206 |
| 2022 | 10 | 357 | 507 | $121,810 | $46,042 |
| 2021 | 10 | 372 | 605 | $143,552 | $52,554 |
| 2020 | 8 | 332 | 629 | $155,942 | $55,018 |
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 113 | 173 | $23,544 | $11,521 | 48.9% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 15 | 85 | $55,048 | $10,769 | 19.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 98 | 113 | $20,080 | $10,259 | 51.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 40 | 43 | $14,190 | $5,906 | 41.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 39 | 39 | $10,810 | $5,002 | 46.3% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 22 | 24 | $9,360 | $4,532 | 48.4% |
| 51990 | Suture suspension of urethra to control leakage using an endoscope | Facility | 2023 | 11 | 11 | $10,320 | $2,522 | 24.4% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 23 | 42 | $6,972 | $1,942 | 27.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $3,071 | $1,111 | 36.2% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 16 | 36 | $1,728 | $1,001 | 57.9% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 36 | 51 | $6,120 | $410.85 | 6.7% |
| 51700 | Simple bladder irrigation and/or instillation | Facility | 2023 | 11 | 12 | $1,980 | $230.47 | 11.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 56 | 59 | $19,470 | $9,293 | 47.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 68 | 91 | $15,323 | $9,138 | 59.6% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 12 | 60 | $37,056 | $8,264 | 22.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 94 | 128 | $17,280 | $7,858 | 45.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 20 | 21 | $8,190 | $4,156 | 50.7% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2022 | 31 | 49 | $8,085 | $2,795 | 34.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $6,510 | $2,156 | 33.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 16 | 16 | $4,112 | $1,408 | 34.2% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 12 | 23 | $1,104 | $651.06 | 59.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 27 | 39 | $4,680 | $323.01 | 6.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 128 | 231 | $29,838 | $15,580 | 52.2% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2021 | 19 | 89 | $54,632 | $11,784 | 21.6% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 35 | 35 | $13,650 | $6,766 | 49.6% |
About Dr. Avinash Chenam, M.D
Dr. Avinash Chenam, M.D is a Urology healthcare provider based in San Bernardino, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2010. The National Provider Identifier (NPI) number assigned to this provider is 1841502986.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Avinash Chenam, M.D has received a total of $72,529 in payments from pharmaceutical and medical device companies, with $24,279 received in 2024. These payments were reported across 368 transactions from 45 companies. The most common payment nature is "Education" ($49,429).
As a Medicare-enrolled provider, Chenam has provided services to 1,497 Medicare beneficiaries, totaling 2,382 services with total Medicare billing of $208,819. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location San Bernardino, CA
- Active Since 07/06/2010
- Last Updated 09/18/2018
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1841502986
Products in Payments
- Da Vinci Surgical System (Device) $59,050
- DAVINCI XI (Device) $4,000
- AMS (Device) $1,384
- AQUABEAM SYSTEM (Device) $1,088
- XTANDI (Drug) $588.25
- NEOX (Medical Supply) $564.97
- ELIGARD (Drug) $467.87
- LUPRON DEPOT (Drug) $462.02
- ORGOVYX (Drug) $431.72
- PROVENGE (Drug) $364.26
- INTERSTIM (Device) $263.00
- Nubeqa (Drug) $204.10
- Olympus Cysto-Resection (Device) $202.89
- ERLEADA (Drug) $166.96
- SpeediCath (Device) $149.67
- TOVIAZ (Drug) $149.47
- GENERAL - MALE SUI (Device) $146.34
- UroLift System (Device) $125.46
- ADVANCE (Device) $124.67
- LITHOVUE (Device) $123.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in San Bernardino
Dr. Steve Dong, M.d, M.D
Urology — Payments: $24,804
Franklin Chu, Md, MD
Urology — Payments: $22,760
Sun Kim, Md, MD
Urology — Payments: $21,552
Daniel Lama, Md, MD
Urology — Payments: $14,179
David Koslov, Md, MD
Urology — Payments: $4,359
Vincent Wong
Urology — Payments: $2,408